299 related articles for article (PubMed ID: 2828628)
1. Survey of nonhuman primates for antibodies reactive with Epstein-Barr virus (EBV) antigens and susceptibility of their lymphocytes for immortalization with EBV.
Ishida T; Yamamoto K
J Med Primatol; 1987; 16(6):359-71. PubMed ID: 2828628
[TBL] [Abstract][Full Text] [Related]
2. Epstein-Barr virus antibodies in patients with ataxia-telangiectasia and other immunodeficiency diseases.
Joncas JH; Wills A; Reece E; Fox Z
Can Med Assoc J; 1981 Oct; 125(8):845-9. PubMed ID: 6272957
[TBL] [Abstract][Full Text] [Related]
3. [Simultaneous detection of IgM antibodies against the hepatitis A virus and the viral capsid antigen of Epstein-Barr virus in acute hepatitis].
Naveau S; Delfraissy JF; Poitrine A; Poynard T; Chaput JC
Gastroenterol Clin Biol; 1985 Feb; 9(2):109-12. PubMed ID: 2984075
[TBL] [Abstract][Full Text] [Related]
4. Immune response to Epstein-Barr virus (EBV) in ataxia-telangiectasia: EBV-specific antibody patterns and their relation to cell-mediated immunity.
Berkel AI; Henle W; Henle G; Ersoy F; Sanal O; Klein G; Yeğin O
Kroc Found Ser; 1985; 19():287-300. PubMed ID: 2999343
[TBL] [Abstract][Full Text] [Related]
5. Epstein-Barr virus (EBV) antibodies in children with non-Hodgkin's lymphomas.
Roubalová K; Weinreb M; Roubal J; Kodet R; Koutecký J; Vonka V
Acta Virol; 1988 Jul; 32(4):339-48. PubMed ID: 2903639
[TBL] [Abstract][Full Text] [Related]
6. Distinct patterns of viral antigen expression in Epstein-Barr virus and Kaposi's sarcoma-associated herpesvirus coinfected body-cavity-based lymphoma cell lines: potential switches in latent gene expression due to coinfection.
Callahan J; Pai S; Cotter M; Robertson ES
Virology; 1999 Sep; 262(1):18-30. PubMed ID: 10489337
[TBL] [Abstract][Full Text] [Related]
7. A new animal model for primary and persistent Epstein-Barr virus infection: human EBV-infected rabbit characteristics determined using sequential imaging and pathological analysis.
Takashima K; Ohashi M; Kitamura Y; Ando K; Nagashima K; Sugihara H; Okuno K; Sairenji T; Hayashi K
J Med Virol; 2008 Mar; 80(3):455-66. PubMed ID: 18205213
[TBL] [Abstract][Full Text] [Related]
8. Characterization of natural Epstein-Barr virus infection and replication in smooth muscle cells from a leiomyosarcoma.
Jenson HB; Montalvo EA; McClain KL; Ench Y; Heard P; Christy BA; Dewalt-Hagan PJ; Moyer MP
J Med Virol; 1999 Jan; 57(1):36-46. PubMed ID: 9890420
[TBL] [Abstract][Full Text] [Related]
9. Serological evidence for active Epstein-Barr virus infection in multifocal choroiditis.
Bhende PS; Biswas J; Madhavan HN
Indian J Pathol Microbiol; 1997 Apr; 40(2):129-31. PubMed ID: 9257497
[TBL] [Abstract][Full Text] [Related]
10. Development of immunity to Epstein-Barr virus in Malaysian children.
Yadav MS; Malliga N; Ablashi DV
Microbiologica; 1987 Jan; 10(1):29-35. PubMed ID: 3033449
[TBL] [Abstract][Full Text] [Related]
11. [Rheumatoid arthritis associated nuclear antigen (RANA) and Epstein-Barr virus (EBV)].
Li ZG
Zhonghua Yi Xue Za Zhi; 1988 Aug; 68(8):447-9, 32. PubMed ID: 2852534
[No Abstract] [Full Text] [Related]
12. Epstein-Barr virus infection in peripheral blood mononuclear cells, synovial fluid cells, and synovial membranes of patients with rheumatoid arthritis.
Blaschke S; Schwarz G; Moneke D; Binder L; Müller G; Reuss-Borst M
J Rheumatol; 2000 Apr; 27(4):866-73. PubMed ID: 10782808
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of the expression of Epstein-Barr virus antigens in vitro by Chinese medicine compound "Dongxia wan".
Huang P; Deng H; Zhao M
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2000 Jun; 14(2):128-30. PubMed ID: 11503041
[TBL] [Abstract][Full Text] [Related]
14. Comparison of plasma Epstein-Barr virus (EBV) DNA levels and serum EBV immunoglobulin A/virus capsid antigen antibody titers in patients with nasopharyngeal carcinoma.
Shao JY; Li YH; Gao HY; Wu QL; Cui NJ; Zhang L; Cheng G; Hu LF; Ernberg I; Zeng YX
Cancer; 2004 Mar; 100(6):1162-70. PubMed ID: 15022282
[TBL] [Abstract][Full Text] [Related]
15. Aberrant Epstein-Barr virus persistence in HIV carriers is characterized by anti-Epstein-Barr virus IgA and high cellular viral loads with restricted transcription.
Stevens SJ; Smits PH; Verkuijlen SA; Rockx DA; van Gorp EC; Mulder JW; Middeldorp JM
AIDS; 2007 Oct; 21(16):2141-9. PubMed ID: 18090040
[TBL] [Abstract][Full Text] [Related]
16. [A comparison of the detection of IgM antibodies against the viral capsid antigen (VCA) of EBV (Epstein-Barr virus) in various groups of patients, using indirect immunofluorescence, indirect ELISA and reverse ELISA. Study of the diagnostic efficacy of the anti-VCA EBV IgM ELISA-VIDITEST kit].
Pumannová M; Rezbová M; Svecová M; Hrbácková H; Novotná M; Ochotná J; Roubalová K
Klin Mikrobiol Infekc Lek; 2004 Aug; 10(4):186-90. PubMed ID: 15328576
[TBL] [Abstract][Full Text] [Related]
17. An unusually high-titer human anti-Epstein Barr virus (EBV) serum and its use in the study of EBV-specific proteins synthesized in vitro and in vivo.
Edson CM; Cohen LK; Henle W; Strominger JL
J Immunol; 1983 Feb; 130(2):919-24. PubMed ID: 6294181
[TBL] [Abstract][Full Text] [Related]
18. Native early antigen of Epstein-Barr virus, a promising antigen for diagnosis of nasopharyngeal carcinoma.
Paramita DK; Fachiroh J; Artama WT; van Benthem E; Haryana SM; Middeldorp JM
J Med Virol; 2007 Nov; 79(11):1710-21. PubMed ID: 17854043
[TBL] [Abstract][Full Text] [Related]
19. High incidence of elevated antibody titers to Epstein-Barr virus in patients with uveitis.
Touge C; Agawa H; Sairenji T; Inoue Y
Arch Virol; 2006 May; 151(5):895-903. PubMed ID: 16362642
[TBL] [Abstract][Full Text] [Related]
20. Antibodies to Epstein-Barr virus-induced early antigens in blood donors.
Wohlrabe P; Färber I; Wutzler P; Uhlig R
Acta Virol; 1989 Aug; 33(4):344-8. PubMed ID: 2574941
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]